시장보고서

상품코드

1901531

분자진단 시장 : 제품별, 기술별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Molecular Diagnostics Market, By Product, By Technology, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: 2025년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 387 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

분자진단 시장 규모는 2024년 254억 5,689만 달러로 평가되며 2025-2032년까지 4.1%의 연평균 성장률(CAGR)을 보일 것으로 예상됩니다.

분자진단 시장은 정확하고 빠른 질병 조기 발견에 대한 수요 증가를 배경으로 강력한 성장세를 보이고 있습니다. PCR, NGS, ISH, 마이크로어레이, 등온증폭 등의 기술은 감염성 질환, 암, 유전성 질환의 진단 및 혈액 검사에 널리 활용되고 있습니다. HIV, COVID-19, 결핵, 각종 암 등의 질병 유병률 증가로 검사 도입이 지속적으로 증가하고 있습니다. 동반진단, 맞춤의료, 약리유전체학 분야에서의 적용 확대가 시장의 성장을 견인하고 있습니다. 그러나 분자진단 시장은 검사 및 장비의 높은 비용, 복잡한 규제 승인 등의 제약에 직면해 있습니다.

분자진단 시장 - 시장 역학

감염 및 암 유병률 증가

분자진단, 특히 PCR, 실시간 PCR, 등온증폭법은 바이러스나 박테리아의 양이 매우 적은 경우에도 병원체를 조기에 식별할 수 있습니다. 이를 통해 적시에 치료 결정을 내리고, 발병을 통제하며, 효과적인 환자 관리를 할 수 있습니다. 또한, 바이러스의 새로운 변종과 항균제 내성 동향은 분자 수준에서의 검사에 대한 의존도를 더욱 높이고 있습니다. 감염성 질환과 암의 유병률 증가는 분자진단 시장의 성장을 견인하는 주요 요인입니다. HIV, B형, C형 간염, 결핵, 독감, 호흡기 감염, 신종 바이러스 위협 등의 감염성 질환은 신속하고 정확하며 고감도의 검출법이 요구됩니다. 세계보건기구(WHO)가 발표한 자료에 따르면, 2024년 말 기준 전 세계적으로 약 4,080만 명이 HIV에 감염된 것으로 추정되며, 이 중 3,940만 명은 성인, 140만 명은 어린이로 집계됐습니다. 같은 해, 전 세계적으로 약 130만 명이 새롭게 HIV에 감염되었습니다. 또한, 2024년에는 약 63만 명이 에이즈 관련 질병으로 사망할 것으로 예상되며, 이는 2010년 이후 에이즈 관련 사망자 수가 54% 감소했음을 의미합니다. 이처럼 질병 부담의 증가, 조기 발견의 필요성, 그리고 정밀의료의 적용 확대는 전 세계적으로 분자진단 기술의 채택을 크게 가속화하고 있습니다.

분자진단 시장 - 시장 세분화 분석:

세계 분자진단 시장은 제품, 기술, 응용 분야, 최종사용자, 지역별로 세분화되어 있습니다.

제품별로는 시약·키트, 장비·시스템, 소프트웨어·서비스의 3가지 카테고리로 분류됩니다. 시약과 키트는 검사 빈도가 높기 때문에 주류를 차지하고, 장비와 시스템은 자동화와 정확성을 지원하며, 소프트웨어 서비스는 효율적인 데이터 분석, 워크플로우 관리, 통합을 실현합니다.

기술별로는 PCR, 차세대염기서열분석(NGS), ISH(In Situ Hybridization), 칩 마이크로어레이, 질량 분석, 기타 기술 등 6가지 카테고리로 분류됩니다. NGS는 유전체 프로파일링을 가능하게 하고, ISH(In Situ Hybridization)은 공간 분석을 제공합니다. 마이크로어레이와 질량 분석은 다중화 및 정확도를 향상시키고, 다른 기술은 전문적이고 새로운 진단 용도를 지원합니다.

분자진단 시장 - 지역별 분석

북미는 선진화된 의료 인프라, PCR 및 NGS 기술의 높은 보급률, 주요 기업의 강력한 존재감, 그리고 탄탄한 상환제도로 인해 시장을 선도하고 있습니다. 유럽은 암 진단 및 감염 검사 증가, 정밀의료에 대한 정부 지원에 힘입어 북미에 이어 성장하고 있습니다. 아시아태평양은 의료 접근성 확대, 만성질환 부담 증가, 대규모 환자 인구, 중국, 인도, 일본 등의 국가에서 유전체학 및 검사실 자동화에 대한 투자 증가에 힘입어 가장 빠르게 성장하고 있는 지역입니다. 라틴아메리카는 진단 능력 향상과 공중보건 프로그램 확대에 힘입어 완만한 성장세를 보이고 있습니다. 중동 및 아프리카는 여전히 신흥 시장으로 비용 제약으로 인해 성장이 제한적이지만, 의료 인프라의 점진적인 개선과 감염성 질환 검진 노력에 힘입어 성장세를 이어가고 있습니다.

분자진단 시장 - 국가별 인사이트

미국 분자진단 시장은 놀라운 CAGR을 보이고 있습니다. 이러한 성장은 주로 진단 기술의 발전, 맞춤형 의료에 대한 수요 증가, 국내 감염 및 암 발생률 증가에 의해 주도되고 있습니다. 미국 의료시스템이 조기 질병 발견과 정밀의료에 중점을 두고 있는 것이 병원, 진단센터, 연구기관에서 분자진단을 광범위하게 보급하는 데 기여하고 있습니다. 액체 생검 및 차세대 염기서열 분석(NGS)과 같은 주요 기술은 특히 종양학 분야에서 진단 정확도와 표적 치료법 선택을 개선하기 위해 점점 더 많이 활용되고 있습니다. 또한, COVID-19, 독감, HIV 등 감염성 질환의 확산으로 인해 신속하고 정확한 분자 검사에 대한 수요가 증가하고 있습니다.

개요
- 부문 점유율 분석 : 용도별
- 종양학
  - 유방암
  - 전립선암
  - 대장암
  - 기타
- 감염증
  - 호흡기 감염
  - 성감염증
  - 혈액 감염
  - 결핵 및 비결핵성 항산균감염증
  - 기타
- 약물유전체학
- 미생물학
- 유전성 질환 스크리닝
- 인간 백혈구 항원 타이핑
- 혈액 스크리닝
- 기타

제10장 분자진단 시장 : 최종사용자별

개요
- 부문 점유율 분석 : 최종사용자별
- 병원
- 진단·검사기관
- 학술·연구기관
- 기타 최종사용자

제11장 분자진단 시장 : 지역별

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 : 분자진단 업계

경쟁 대시보드
- 경쟁 벤치마크
- 경쟁 포지셔닝
기업 개요
- BD
- Abbott
- F. Hoffmann-La Roche, Ltd.
- Agilent Technologies, Inc.
- Danaher Corporation
- Siemens Healthineers AG
- Agilent Technologies Inc.
- Hologic Inc.(Gen Probe)
- Sysmex Corporation
- Illumina Inc.
- Others

제13장 애널리스트의 전방위적 전망

KSM 26.01.21

The Molecular Diagnostics Market size was valued at US$ 25,456.89 Million in 2024, expanding at a CAGR of 4.1% from 2025 to 2032.

The molecular diagnostics market is experiencing strong growth driven by rising demand for precise, rapid, and early disease detection. Technologies such as PCR, NGS, ISH, microarrays, and isothermal amplification are widely used for diagnosing infectious diseases, cancer, genetic disorders, and for blood screening. Increasing prevalence of conditions like HIV, COVID-19, tuberculosis, and various cancers continues to boost test adoption. Growing applications in companion diagnostics, personalized medicine, and pharmacogenomics further strengthen market expansion. However, the Molecular diagnostics market faces restraints such as high test and equipment costs, complex regulatory approvals, and others.

Molecular Diagnostics Market- Market Dynamics

Rising prevalence of infectious diseases and cancers

Molecular diagnostics, especially PCR, real-time PCR, and isothermal amplification, allow early identification of pathogens, even at very low viral or bacterial loads. This supports timely treatment decisions, outbreak control, and effective patient management. Additionally, new variants of viruses and antimicrobial resistance trends further increase dependence on molecular-level testing. The rising prevalence of infectious diseases and cancers is a major force driving the growth of the molecular diagnostics market. Infectious diseases such as HIV, hepatitis B and C, tuberculosis, influenza, respiratory infections, and emerging viral threats require rapid, accurate, and sensitive detection methods. According to the data published by the World Health Organization, at the end of 2024, an estimated 40.8 million people worldwide were living with HIV, including 39.4 million adults and 1.4 million children. In that year, about 1.3 million people acquired HIV globally. Additionally, around 630,000 people died from AIDS-related illnesses in 2024, marking a 54% reduction in AIDS-related deaths since 2010. Thus, growing disease burden, need for early detection, and expanding precision medicine applications are significantly accelerating the adoption of molecular diagnostics worldwide.

Molecular Diagnostics Market- Segmentation Analysis:

The Global Molecular Diagnostics Market is segmented on the basis of Product, Technology, Application, End User, and Region.

The market is divided into three categories based on Product: Reagents & Kits, Instruments & Systems, and Software & Services. Reagents & kits dominate due to high testing frequency, while instruments & systems support automation and accuracy, and software & services enable efficient data analysis, workflow management, and integration.

The market is divided into six categories based on Technology: PCR, Next-Generation Sequencing (NGS), In Situ Hybridization, Chips & Microarrays, Mass Spectrometry, and Other Technologies. NGS enables genomic profiling; In situ Hybridization offers spatial analysis; microarrays and mass spectrometry enhance multiplexing and precision, while other technologies support specialised and emerging diagnostic applications.

Molecular Diagnostics Market- Geographical Insights

North America leads the market due to advanced healthcare infrastructure, high adoption of PCR and NGS technologies, strong presence of major companies, and robust reimbursement systems. Europe follows closely, driven by rising cancer diagnostics, infectious disease testing, and government support for precision medicine. Asia-Pacific is the fastest-growing region, supported by expanding healthcare access, rising chronic disease burden, large patient populations, and increasing investments in genomics and laboratory automation in countries like China, India, and Japan. Latin America shows moderate growth, driven by improving diagnostic capacity and expanding public health programs. Middle East & Africa remain emerging markets, with growth limited by cost constraints but supported by gradual improvements in healthcare infrastructure and infectious disease screening initiatives.

Molecular Diagnostics Market- Country Insights

The United States molecular diagnostics market was reflecting a significant CAGR. This growth is primarily driven by advancements in diagnostic technologies, increasing demand for personalised medicine, and a rising incidence of infectious diseases and cancer in the country. The U.S. healthcare system's focus on early disease detection and precision medicine contributes to the widespread adoption of molecular diagnostics across hospitals, diagnostic centres, and research institutions. Key technologies such as liquid biopsy and next-generation sequencing (NGS) are increasingly utilised to enhance diagnostic accuracy and targeted therapy selection, especially in oncology. Additionally, the rising prevalence of infectious diseases like COVID-19, influenza, and HIV fuels demand for rapid and accurate molecular testing.

Molecular Diagnostics Market- Competitive Landscape:

The molecular diagnostics market's competitive landscape in 2025 is led by several major global players that drive innovation and market growth through robust product portfolios, technological advancements, and strategic expansions. For instance, in August 2024, Sysmex Corporation expanded its strategic alliance with QIAGEN to deepen collaboration in genetic testing, covering research and development, production, clinical trials, and global sales and marketing. This alliance builds upon their initial 2021 partnership focused on cancer companion diagnostics using ultra-sensitive liquid biopsy NGS technology. Additionally, the market players are actively engaged in regulatory approvals, acquisitions, and partnerships to enhance their market presence. Moreover, the collaborative efforts of market players, coupled with continuous R&D, enable the molecular diagnostics market to grow robustly, addressing diverse clinical needs globally.

Recent Developments:

In March 2025, Danaher Corporation, through subsidiaries like Beckman Coulter, is investing in automated and high-throughput molecular diagnostic solutions to support diverse clinical needs.

In February 2023, Becton Dickinson (BD) received FDA Emergency Use Authorisation (EUA) for a molecular diagnostic test capable of detecting and differentiating COVID-19, influenza A/B, and respiratory syncytial virus (RSV). This test, designed for use on the BD MAX Molecular Diagnostic System, uses a single nasal or nasopharyngeal swab sample.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

BD
Abbott
F. Hoffmann-La Roche, Ltd.
Agilent Technologies, Inc.
Danaher Corporation
Siemens Healthineers AG
Agilent Technologies Inc.
Hologic Inc. (Gen Probe)
Sysmex Corporation
Illumina Inc.
Others

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Reagents & Kits
Instruments & Systems
Software & Services

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

PCR
Next-Generation Sequencing (NGS)
In Situ Hybridization
Chips & Microarrays
Mass Spectrometry
Other Technologies

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Oncology
Breast Cancer
Prostate Cancer
Colorectal Cancer
Others
Infectious Disease
Respiratory Infections
Sexually Transmitted Infections
Blood-borne Infections
Tuberculosis & Non-tuberculous Mycobacteria
Others
Pharmacogenomics
Microbiology
Genetic Disease Screening
Human Leukocyte Antigen Typing
Blood Screening
Others

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic & Reference Laboratories
Academic & Research Institutes
Other End Users

GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Molecular Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Molecular Diagnostics Market Snippet by Product
- 2.1.2. Molecular Diagnostics Market Snippet by Technology
- 2.1.3. Molecular Diagnostics Market Snippet by Application
- 2.1.4. Molecular Diagnostics Market Snippet by End User
- 2.1.5. Molecular Diagnostics Market Snippet by Country
- 2.1.6. Molecular Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Molecular Diagnostics Key Market Trends

3.1. Molecular Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Molecular Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Molecular Diagnostics Market Opportunities
3.4. Molecular Diagnostics Market Future Trends

4. Molecular Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Molecular Diagnostics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Molecular Diagnostics Market Landscape

6.1. Molecular Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Molecular Diagnostics Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Reagents & Kits
- 7.1.3. Instruments & Systems
- 7.1.4. Software & Services

8. Molecular Diagnostics Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 8.1.2. PCR
- 8.1.3. Next-Generation Sequencing (NGS)
- 8.1.4. In Situ Hybridization
- 8.1.5. Chips & Microarrays
- 8.1.6. Mass Spectrometry
- 8.1.7. Other Technologies

9. Molecular Diagnostics Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 9.1.2. Oncology
  - 9.1.2.1. Breast Cancer
  - 9.1.2.2. Prostate Cancer
  - 9.1.2.3. Colorectal Cancer
  - 9.1.2.4. Others
- 9.1.3. Infectious Disease
  - 9.1.3.1. Respiratory Infections
  - 9.1.3.2. Sexually Transmitted Infections
  - 9.1.3.3. Blood-borne Infections
  - 9.1.3.4. Tuberculosis & Non-tuberculous Mycobacteria
  - 9.1.3.5. Others
- 9.1.4. Pharmacogenomics
- 9.1.5. Microbiology
- 9.1.6. Genetic Disease Screening
- 9.1.7. Human Leukocyte Antigen Typing
- 9.1.8. Blood Screening
- 9.1.9. Others

10. Molecular Diagnostics Market - By End User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Diagnostic & Reference Laboratories
- 10.1.4. Academic & Research Institutes
- 10.1.5. Other End Users

11. Molecular Diagnostics Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Molecular Diagnostics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Molecular Diagnostics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Molecular Diagnostics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Molecular Diagnostics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Molecular Diagnostics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Molecular Diagnostics Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. BD
- 12.2.2. Abbott
- 12.2.3. F. Hoffmann-La Roche, Ltd.
- 12.2.4. Agilent Technologies, Inc.
- 12.2.5. Danaher Corporation
- 12.2.6. Siemens Healthineers AG
- 12.2.7. Agilent Technologies Inc.
- 12.2.8. Hologic Inc. (Gen Probe)
- 12.2.9. Sysmex Corporation
- 12.2.10. Illumina Inc.
- 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us